These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6271053)

  • 1. Selective inhibition of herpesvirus deoxyribonucleic acid synthesis by acycloguanosine, 2'-fluoro-5-iodo-aracytosine, and (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Larsson A; Oberg B
    Antimicrob Agents Chemother; 1981 May; 19(5):927-9. PubMed ID: 6271053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyclovir inhibition of viral DNA chain elongation in herpes simplex virus-infected cells.
    McGuirt PV; Furman PA
    Am J Med; 1982 Jul; 73(1A):67-71. PubMed ID: 6285735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and biological consequences of incorporation of antiviral agents into virus DNA.
    Prusoff WH; Mancini WR; Lin TS; Lee JJ; Siegel SA; Otto MJ
    Antiviral Res; 1984 Dec; 4(6):303-15. PubMed ID: 6099709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus: inhibition of replication by three new drugs.
    Lin JC; Smith MC; Cheng YC; Pagano JS
    Science; 1983 Aug; 221(4610):578-9. PubMed ID: 6306771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses.
    Coen N; Duraffour S; Topalis D; Snoeck R; Andrei G
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7312-23. PubMed ID: 25267682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of herpes simplex virus to adenine arabinoside and E-5-(2-bromovinyl)-2'-deoxyuridine: a physical analysis.
    Crumpacker CS; Schnipper LE; Kowalsky PN; Sherman DM
    J Infect Dis; 1982 Aug; 146(2):167-72. PubMed ID: 6286786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoside analogues as antiviral agents.
    de Clercq E
    Acta Microbiol Acad Sci Hung; 1981; 28(3):289-306. PubMed ID: 6272552
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiherpes activity of 5-(2-bromoethyl)-2'-deoxyuridine.
    La Colla P; Gelli G; Mura L; Landini MP; Corrias MV; Pani A; Marongiu ME
    Antiviral Res; 1985; Suppl 1():29-34. PubMed ID: 3002262
    [No Abstract]   [Full Text] [Related]  

  • 9. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
    Schinazi RF; Nahmias AJ
    Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication.
    Wigerinck P; Pannecouque C; Snoeck R; Claes P; De Clercq E; Herdewijn P
    J Med Chem; 1991 Aug; 34(8):2383-9. PubMed ID: 1652017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acyclovir combined with other antiherpetic agents on varicella zoster virus in vitro.
    Biron KK; Elion GB
    Am J Med; 1982 Jul; 73(1A):54-7. PubMed ID: 6285733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [(E)-5-(2-bromovinyl)-2'-desoxyuridine--a new nucleoside analog with selective inhibitory action against herpesviruses. Studies in cell culture and animal experiments].
    Reefschläger J; Wutzler P; Thiel KD; Töpke H; Bärwolff D; Langen P
    Pharmazie; 1987 Jun; 42(6):407-11. PubMed ID: 2823299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.
    Crumpacker CS; Schnipper LE; Marlowe SI; Kowalsky PN; Hershey BJ; Levin MJ
    N Engl J Med; 1982 Feb; 306(6):343-6. PubMed ID: 6275267
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on synthesis of herpes simplex virus type 1-specific polypeptides.
    Siegel SA; Otto MJ; De Clercq E; Prusoff WH
    Antimicrob Agents Chemother; 1984 May; 25(5):566-70. PubMed ID: 6329089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent.
    Lopez C; Watanabe KA; Fox JJ
    Antimicrob Agents Chemother; 1980 May; 17(5):803-6. PubMed ID: 6249196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiherpes drug (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVdU) interferes with formation of N-linked and of O-linked oligosaccharides of the herpes simplex virus type 1 glycoprotein C.
    Olofsson S; Lundström M; Datema R
    Virology; 1985 Nov; 147(1):201-5. PubMed ID: 2998063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiviral spectrum of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    De Clercq E
    J Antimicrob Chemother; 1984 Aug; 14 Suppl A():85-95. PubMed ID: 6092320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative anti-herpesvirus activities of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, acyclovir, and two 2'-fluoropyrimidine nucleosides.
    Smee DF; Campbell NL; Matthews TR
    Antiviral Res; 1985 Oct; 5(5):259-67. PubMed ID: 2998275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiherpes activity of some novel analogues of (E)-5-(2-bromovinyl)-2'-deoxyuridine (E-BrVUdR) in two different cell lines.
    Reefschläger J; Bärwolff D; Herrmann G; Langen P
    Acta Virol; 1984 Jan; 28(1):1-10. PubMed ID: 6143491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on replication of Epstein-Barr virus in human lymphoblastoid cell lines.
    Lin JC; Smith MC; Choi EI; De Clercq E; Verbruggen A; Pagano JS
    Antiviral Res; 1985; Suppl 1():121-6. PubMed ID: 3002251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.